ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 228 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $4,122,000 | +251.4% | 77,106 | +218.6% | 0.33% | +178.3% |
Q2 2020 | $1,173,000 | -86.7% | 24,201 | -90.1% | 0.12% | -74.6% |
Q3 2019 | $8,825,000 | +771.2% | 245,234 | +546.8% | 0.47% | +1110.3% |
Q2 2019 | $1,013,000 | +46.8% | 37,915 | +47.5% | 0.04% | -2.5% |
Q1 2019 | $690,000 | -65.9% | 25,700 | -73.6% | 0.04% | -43.7% |
Q3 2018 | $2,024,000 | +41.9% | 97,500 | +134.9% | 0.07% | +222.7% |
Q1 2017 | $1,426,000 | -51.8% | 41,500 | -54.5% | 0.02% | -84.1% |
Q2 2016 | $2,960,000 | +1025.5% | 91,200 | +1347.6% | 0.14% | +245.0% |
Q2 2015 | $263,000 | -8.7% | 6,300 | -30.8% | 0.04% | -9.1% |
Q4 2014 | $288,000 | -24.4% | 9,100 | -40.9% | 0.04% | -39.7% |
Q3 2014 | $381,000 | -35.1% | 15,400 | -34.5% | 0.07% | +28.1% |
Q4 2013 | $587,000 | – | 23,500 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |